Integrating antiretroviral therapy into antenatal care and maternal and child health settings: A systematic review and meta-analysis;Integración del tratamiento antirretroviral en los centros de atención prenatal y salud materno-infantil: Examen sistemático y metaanálisis

Bulletin of the World Health Organization

Volumn 91, Issue 1, 2013, Pages 46-56

  Suthar, Amitabh B ^a   Hoos, David ^b   Beqiri, Alba ^a   Lorenz Dehne, Karl ^c   McClure, Craig ^d   Duncomb, Chris ^e  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b Department of Medicine   (United States)

^c UNAIDS   (Switzerland)

^d UNITED NATIONS   (United States)

^e BILL AND MELINDA GATES FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

CHILD HEALTH; COHORT ANALYSIS; DISEASE PREVALENCE; HEALTH RISK; HETEROGENEITY; HUMAN IMMUNODEFICIENCY VIRUS; MATERNAL HEALTH; META-ANALYSIS; MORTALITY; PREGNANCY; RISK FACTOR;

COHORT ANALYSIS; DISEASE TRANSMISSION; HEALTH CENTER; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MATERNAL AND CHILD HEALTH CLINIC; META ANALYSIS; OUTCOME ASSESSMENT; PREGNANT WOMAN; PRENATAL CARE; PREVALENCE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; REVIEW; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW;

FEMALE; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MATERNAL-CHILD HEALTH CENTERS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE;

HUMAN IMMUNODEFICIENCY VIRUS; SYRINGA;

EID: 84871906356     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.12.107003     Document Type: Review

References (67)

1. Millenium Development Goals report 2011. New York: United Nations; 2012. Available from: http://mdgs.un.org/unsd/mdg/Resources/Static/Products/Progress2011/11-31339%20(E)%20MDG%20Report%202011_Book%20LR.pdf [accessed 14 November 2012].
2. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Geneva: World Health Organization; 2010. Available from: http://whqlibdoc.who.int/publications/2010/9789241500395_eng.pdf [accessed 14 November 2012].
3. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: recommendations for a public health approach. Geneva: World Health Organization; 2010.
4. Together we will end AIDS. Geneva: Joint United Nations Programme on HIV and AIDS; 2012. Available from: http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/20120718_togetherwewillendaids_en.pdf [accessed 14 November 2012].
5. PMTCT strategic vision 2010-2015. Geneva: World Health Organization; 2010. Available from: http://www.who.int/entity/hiv/pub/mtct/strategic_vision.pdf [accessed 14 November 2012].
6. Global health sector strategy on HIV/AIDS, 2011-2015. Geneva: World Health Organization; 2011. Available from: http://whqlibdoc.who.int/publications/2011/9789241501651_eng.pdf [accessed 14 November 2012].
7. Getting to zero: 2011-2015 strategy. Geneva: Joint United Nations Programme on HIV/AIDS; 2010. Available from: http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2010/JC2034_UNAIDS_Strategy_en.pdf [accessed 14 November 2012].
8. Mugglin C, Althoff K, Wools-Kaloustian K, Sterne J, Nash D, Dabis F et al. Immunodeficiency at the start of ART: global view. In: 19th Conference on Retroviruses and Opportunistic Infections [Internet]; 2012 5-8 March 2012; Seattle, United States of America; 2012.
9. Hirnschall G, Schwartländer B. Treatment 2.0: catalysing the next phase of scale-up. Lancet 2011;378:209-11. doi:10.1016/S0140-6736(11)60247-X PMID:21353697
10. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: towards universal access. Geneva: World Health Organization; 2010. Available from: http://whqlibdoc.who.int/publications/2010/9789241599818_eng.pdf [accessed 14 November 2012].
11. Use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Geneva: World Health Organization; 2012. Available from: http://www.who.int/hiv/PMTCT_update.pdf[[accessed 14 November 2012].
12. Centers for Disease Control and Prevention. Achievements in public health. Reduction in perinatal transmission of HIV infection-United States, 1985-2005. MMWR Morb Mortal Wkly Rep 2006;55:592-7. PMID:16741495
13. Townsend CL, Cortina-Borja M, Peckham CS, de Ruiter A, Lyall H, Tookey PA. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS 2008;22:973-81. doi:10.1097/QAD.0b013e3282f9b67a PMID:18453857
14. Guidance on provider-initiated HIV testing and counselling in health facilities. Geneva: World Health Organization; 2007. Available from: http://whqlibdoc.who.int/publications/2007/9789241595568_eng.pdf [accessed 14 November 2012].
15. Rosen S, Fox MP. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med 2011;8:e1001056. doi:10.1371/journal.pmed.1001056 PMID:21811403
16. Children and AIDS: fifth stocktaking report, 2010. New York: United Nations Children's Fund; 2010. Available from: http://www.unicef.org/publications/files/Children_and_AIDS-Fifth_Stocktaking_Report_2010_EN.pdf [accessed 14 November 2012].
17. Tudor Car L, Van Velthoven MH, Brusamento S, Elmoniry H, Car J, Majeed A et al. Integrating prevention of mother-to-child HIV transmission programs to improve uptake: a systematic review. PLoS One 2012;7:e35268. doi:10.1371/journal.pone.0035268 PMID:22558134
18. Tudor Car L, van-Velthoven MH, Brusamento S, Elmoniry H, Car J, Majeed A et al. Integrating prevention of mother-to-child HIV transmission (PMTCT) programmes with other health services for preventing HIV infection and improving HIV outcomes in developing countries. Cochrane Database Syst Rev 2011;6:CD008741. PMID:21678382
19. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009;6:e1000100. doi:10.1371/journal.pmed.1000100 PMID:19621070
20. Suthar AB. Integrating antiretroviral therapy into antenatal care and maternal and child health clinics: protocol for a systematic review. York: York University; 2011. Available from: http://www.crd.york.ac.uk/PROSPEROFILES/1403_PROTOCOL.pdf [accessed 14 November 2012].
21. Cooper H, Hedges L. The handbook of research synthesis. New York: Russell Sage Foundation; 1994.
22. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58. doi:10.1002/sim.1186 PMID:12111919
23. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60. doi:10.1136/bmj.327.7414.557 PMID:12958120
24. Hedges LV, Vevea JL. Fixed-and random-effects models in meta-analysis. Psychol Methods 1998;3:486-504. doi:10.1037/1082-989X.3.4.486
25. Report on the global AIDS epidemic. Geneva: Joint United Nations Programme on HIV/AIDS; 2010. Available from: http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2010/20101123_globalreport_en.pdf [accessed 14 November 2012].
26. Millenium Development Goals Indicators [Internet]. Antenatal care coverage, at least four visits, percentage. New York: United Nations; 2011. Available from: http://unstats.un.org/unsd/mdg/SeriesDetail.aspx?srid=763 [accessed 14 November 2012].
27. Namukwaya Z, Mudiope P, Kekitiinwa A, Musoke P, Matovu J, Kayma S et al. The impact of maternal highly active antiretroviral therapy and short-course combination antiretrovirals for prevention of mother-to-child transmission on early infant infection rates at the Mulago national referral hospital in Kampala, Uganda, January 2007 to May 2009. J Acquir Immune Defic Syndr 2011;56:69-75. doi:10.1097/QAI.0b013e3181fdb4a8 PMID:21099692
28. Black V, Hoffman RM, Sugar CA, Menon P, Venter F, Currier JS et al. Safety and efficacy of initiating highly active antiretroviral therapy in an integrated antenatal and HIV clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr 2008;49:276-81. doi:10.1097/QAI.0b013e318189a769 PMID:18845949
29. Christie CD, Steel-Duncan J, Palmer P, Pierre R, Harvey K, Johnson N et al. Paediatric and perinatal HIV/AIDS in Jamaica an international leadership initiative, 2002-2007. West Indian Med J 2008;57:204-15. PMID:19583118
30. Killam WP, Tambatamba BC, Chintu N, Rouse D, Stringer E, Bweupe M et al. Antiretroviral therapy in antenatal care to increase treatment initiation in HIV-infected pregnant women: a stepped-wedge evaluation. AIDS 2010;24:85-91. doi:10.1097/QAD.0b013e32833298be PMID:19809271
31. Pfeiffer J, Montoya P, Baptista AJ, Karagianis M, Pugas MM, Micek M et al. Integration of HIV/AIDS services into African primary health care: lessons learned for health system strengthening in Mozambique-a case study. J Int AIDS Soc 2010;13:3. doi:10.1186/1758-2652-13-3 PMID:20180975
32. Tsague L, Tsiouris FO, Carter RJ, Mugisha V, Tene G, Nyankesha E et al. Comparing two service delivery models for the prevention of mother-to-child transmission (PMTCT) of HIV during transition from single-dose nevirapine to multi-drug antiretroviral regimens. BMC Public Health 2010;10:753. doi:10.1186/1471-2458-10-753 PMID:21134259
33. ClinicalTrials. gov [Internet]. Integration of HIV care and treatment into antenatal care in Migori District, Kenya. Bethesda: National Institutes of Health. [Record last processed 13 November 2012]. Available from: http://clinicaltrials.gov/show/NCT00931216 [accessed 14 November 2012].
34. Sterne JA, Gavaghan D, Egger M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol 2000;53:1119-29. doi:10.1016/S0895-4356(00)00242-0 PMID:11106885
35. Stinson K, Boulle A, Coetzee D, Abrams EJ, Myer L. Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa. Trop Med Int Health 2010;15:825-32. doi:10.1111/j.1365-3156.2010.02538.x PMID:20497405
36. van der Merwe K, Chersich MF, Technau K, Umurungi Y, Conradie F, Coovadia A. Integration of antiretroviral treatment within antenatal care in Gauteng Province, South Africa. J Acquir Immune Defic Syndr 2006;43:577-81. PMID:17031321
37. Youngleson MS, Nkurunziza P, Jennings K, Arendse J, Mate KS, Barker P. Improving a mother to child HIV transmission programme through health system redesign: quality improvement, protocol adjustment and resource addition. PLoS One 2010;5:e13891. doi:10.1371/journal.pone.0013891 PMID:21085479
38. Ong'ech JO, Hoffman HJ, Kose J, Audo M, Matu L, Savosrick P et al. Provision of services and care for HIV-exposed infants: a comparison of maternal and child health clinic and HIV comprehensive care clinic models. J Acquir Immune Defic Syndr 2012;61:83-9. PMID:22592589
39. Sprague C, Chersich MF, Black V. Health system weaknesses constrain access to PMTCT and maternal HIV services in South Africa: a qualitative enquiry. AIDS Res Ther 2011;8:10. doi:10.1186/1742-6405-8-10 PMID:21371301
40. Bwirire LD, Fitzgerald M, Zachariah R, Chikafa V, Massaquoi M, Moens M et al. Reasons for loss to follow-up among mothers registered in a prevention-of-mother-to-child transmission program in rural Malawi. Trans R Soc Trop Med Hyg 2008;102:1195-200. doi:10.1016/j.trstmh.2008.04.002 PMID:18485431
41. Duff P, Kipp W, Wild TC, Rubaale T, Okech-Ojony J. Barriers to accessing highly active antiretroviral therapy by HIV-positive women attending an antenatal clinic in a regional hospital in western Uganda. J Int AIDS Soc 2010;13:37. doi:10.1186/1758-2652-13-37 PMID:20863399
42. Muchedzi A, Chandisarewa W, Keatinge J, Stranix-Chibanda L, Woelk G, Mbizvo E et al. Factors associated with access to HIV care and treatment in a prevention of mother to child transmission programme in urban Zimbabwe. J Int AIDS Soc 2010;13:38. doi:10.1186/1758-2652-13-38 PMID:20925943
43. Winestone LE, Bukusi EA, Cohen CR, Kwaro D, Schmidt NC, Turan JM et al. Acceptability and feasibility of integration of HIV care services into antenatal clinics in rural Kenya: a qualitative provider interview study. Glob Public Health 2012;7:149-63. doi:10.1080/17441692.2011.621964 PMID:22043837
44. Hoffman RM, Black V, Technau K, van der Merwe KJ, Currier J, Coovadia A et al. Effects of highly active antiretroviral therapy duration and regimen on risk for mother-to-child transmission of HIV in Johannesburg, South Africa. J Acquir Immune Defic Syndr 2010;54:35-41. PMID:20216425
45. Chibwesha CJ, Giganti MJ, Putta N, Chintu N, Mulindwa J, Dorton BJ et al. Optimal time on HAART for prevention of mother-to-child transmission of HIV. J Acquir Immune Defic Syndr 2011;58:224-8. doi:10.1097/QAI.0b013e318229147e PMID:21709566
46. Chen JY, Ogwu AC, Svab P, Lockman S, Moffat HJ, Gaolathe T et al. Antiretroviral treatment initiation among HIV-infected pregnant women with low CD4(+) cell counts in Gaborone, Botswana. J Acquir Immune Defic Syndr 2010;54:102-6. PMID:19864957
47. Chi BH, Chintu N, Lee A, Stringer EM, Sinkala M, Stringer JSA. Expanded services for the prevention of mother-to-child HIV transmission: field acceptability of a pilot program in Lusaka, Zambia. J Acquir Immune Defic Syndr 2007;45:125-7. doi:10.1097/QAI.0b013e318050d28f PMID:17460478
48. Ferguson L, Lewis J, Grant AD, Watson-Jones D, Vusha S, Ong'ech JO et al. Patient attrition between diagnosis with HIV in pregnancy-related services and long-term HIV care and treatment services in Kenya: a retrospective study. J Acquir Immune Defic Syndr 2012;60:e90-7. PMID:22421747
49. Njom Nlend AE, Mboua Bitoungui J, Same Ekobo C. Feasibility and bottlenecks of highly active antiretroviral therapy (HAART) to prevent mother-to-child transmission (PMTCT) of HIV in a routine program in Cameroon. In: XVIII International AIDS Conference [Internet]; 18-23 July 2010; Vienna, Austria.
50. Braun M, Kabue MM, McCollum ED, Ahmed S, Kim M, Aertker L et al. Inadequate coordination of maternal and infant HIV services detrimentally affects early infant diagnosis outcomes in Lilongwe, Malawi. J Acquir Immune Defic Syndr 2011;56:e122-8. doi:10.1097/QAI.0b013e31820a7f2f PMID:21224736
51. Gabrysch S, Campbell OM. Still too far to walk: literature review of the determinants of delivery service use. BMC Pregnancy Childbirth 2009;9:34. doi:10.1186/1471-2393-9-34 PMID:19671156
52. Fox MP, Rosen S. Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review. Trop Med Int Health 2010;15:1-15.
53. Integrated HIV Program report: April-June 2012. Lilongwe: Ministry of Health; 2012. Available from: http://www.hivunitmohmw.org/uploads/Main/Quarterly_HIV_Programme_Report_2012_Q2.pdf [accessed on 5 December 2012].
54. Gartland M, Chintu N, Li M, Musonda P, Mulenga S et al. Field effectiveness of universal ART for PMTCT: rural Zambia. In: 19th Conference on Retroviruses and Opportunistic Infections [Internet]; 5-8 March 2012; Seattle, United States of America; 2012.
55. Carter RJ, Dugan K, El-Sadr WM, Myer L, Otieno J, Pungpapong N et al.; MTCT Plus Initiative. CD4+ cell count testing more effective than HIV disease clinical staging in identifying pregnant and postpartum women eligible for antiretroviral therapy in resource-limited settings. J Acquir Immune Defic Syndr 2010;55:404-10. doi:10.1097/QAI.0b013e3181e73f4b PMID:20595905
56. Malawi Demographic and Health Survey. Zomba & Calverton: Malawi National Statistic Office & ICF Macro; 2010. Available from: http://www.measuredhs.com/pubs/pdf/FR247/FR247.pdf [accessed 14 November 2012].
57. El-Sadr WM, Lundgren JD, Neaton JD, Gordin F, Abrams D, Arduino RC et al.; Strategies for Management of Antiretroviral Therapy (SMART) Study Group. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med 2006;355:2283-96. doi:10.1056/NEJMoa062360 PMID:17135583
58. Oyugi JH, Byakika-Tusiime J, Ragland K, Laeyendecker O, Mugerwa R, Kityo C et al. Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda. AIDS 2007;21:965-71. doi:10.1097/QAD.0b013e32802e6bfa PMID:17457090
59. Zolfo M, De Weggheleire A, Schouten E, Lynen L. Time for "test and treat" in prevention of mother-to-child transmission programs in low-and middle-income countries. J Acquir Immune Defic Syndr 2010;55:287-9. doi:10.1097/QAI.0b013e3181eef3da PMID:20714271
60. Becquet R, Ekouevi DK, Arrive E, Stringer JS, Meda N, Chaix M-L et al. Universal antiretroviral therapy for pregnant and breast-feeding HIV-1-infected women: towards the elimination of mother-to-child transmission of HIV-1 in resource-limited settings. Clin Infect Dis 2009;49:1936-45. doi:10.1086/648446 PMID:19916796
61. Russo G, Lichtner M, Traditi F, Vullo V. Is the time for an AIDS-free new generation different in resource-limited and industrialized countries? AIDS 2009;23:293-6. doi:10.1097/QAD.0b013e32831c54aa PMID:19114853
62. Schouten EJ, Jahn A, Midiani D, Makombe SD, Mnthambala A, Chirwa Z et al. Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach. Lancet 2011;378:282-4. doi:10.1016/S0140-6736(10)62303-3 PMID:21763940
63. Harmonized monitoring and evaluation indicators for procurement and supply management systems. Geneva: World Health Organization; 2011. Available from: http://whqlibdoc.who.int/publications/2011/9789241500814_eng.pdf [accessed 14 November 2012].
64. Three interlinked patient monitoring systems for HIV care/ART, MCH/PMTCT (including malaria prevention during pregnancy), and TB/HIV: standardized minimum data set and illustrative tool. Geneva: World Health Organization; 2010. Available from: http://www.who.int/entity/hiv/pub/imai/forms_booklet.pdf [accessed 14 November 2012].
65. Couples HIV testing and counselling including antiretroviral therapy for treatment and prevention in serodiscordant couples. Geneva: World Health Organization; 2012. Available from: http://whqlibdoc.who.int/publications/2012/9789241501972_eng.pdf [accessed 14 November 2012].
66. Mohlala BKF, Boily M-C, Gregson S. The forgotten half of the equation: randomised controlled trial of a male invitation to attend couple VCT in Khayelitsha, South Africa. AIDS 2011;25:1535-41. doi:10.1097/QAD.0b013e328348fb85 PMID:21610487
67. Ditekemena J, Matendo R, Koole O, Colebunders R, Kashamuka M, Tshefu A et al. Male partner voluntary counselling and testing associated with the antenatal services in Kinshasa, Democratic Republic of Congo: a randomized controlled trial. Int J STD AIDS 2011;22:165-70. doi:10.1258/ijsa.2010.010379 PMID:21464455